The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance
- 16 March 2000
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1470 (2), M55-M62
- https://doi.org/10.1016/s0304-419x(00)00002-0
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Suppression of TNF?-mediated NF?b activity by myricetin and other flavonoids through downregulating the activity of IKK in ECV304 cellsJournal of Cellular Biochemistry, 1999
- Induction of NF-κB by the Akt/PKB kinaseCurrent Biology, 1999
- IκB Kinases: Kinsmen with Different CraftsScience, 1999
- The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappa B that blocks TNFalpha -induced apoptosisGenes & Development, 1999
- HTLV-I Tax Protein Binds to MEKK1 to Stimulate IκB Kinase Activity and NF-κB ActivationCell, 1998
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell DeathCell, 1996
- TGFβ1 Inhibits NF-κB/Rel Activity Inducing Apoptosis of B Cells: Transcriptional Activation of IκBαImmunity, 1996
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Inhibition of NF-κB by Sodium Salicylate and AspirinScience, 1994